Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-hodgkin's lymphoma: A pediatric oncology group study

Leukemia and Lymphoma

Volumn 43, Issue 1, 2002, Pages 105-109

  Laver, Joseph H ^a   Mahmoud, Hazem ^b   Pick, Terry E ^c   Hutchison, Robert E ^d   Weinstein, Howard J ^e   Schwenn, Molly ^f   Weitzman, Sheilah ^g   Murphy, Sharon B ^c   Ochoa, Stephanie ^h   Shuster, Jonathan J ^h  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h UNIVERSITY OF FLORIDA   (United States)

Author keywords

ACOP+ chemotherapy; APO chemotherapy; CD30+ lymphoma; Diffuse large cell lymphoma; Pediatric non Hodgkin's lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE; ACOP PROTOCOL 2; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADVANCED CANCER; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLAST; INFECTION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM MASS; NONHODGKIN LYMPHOMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT PLANNING; DISEASE FREE SURVIVAL; METHODOLOGY; MORTALITY; RECURRENT DISEASE; REMISSION; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; PREDNISONE; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 18344363366     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190210192     Document Type: Article

References (24)

1. "Pediatric lymphomas: Recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhood"
2. "Malignant non-Hodgkin's lymphomas in children"
3. "National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The non-Hodgkin's Lymphoma Pathologic Classification Project"
4. "Clinical significance of histology and immunophenotype in childhood diffuse large cell lymphoma"
5. "Nonlymphoblastic lymphoma in children-histology and stage-related response to therapy: A Pediatric Oncology Group study"
6. "APO therapy for malignant lymphoma of large cell histiocytic type of childhood: Analysis of treatment results for 29 patients"
7. "High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: Results of a Pediatric Oncology Group study"
8. "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma"
9. "General principles of chemotheraphy"
10. "Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: Dissimilarities from lymphomas in adults"
11. "B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: A Pediatric Oncology Group study"
12. "Nonparametric estimation from incomplete observations"
13. "Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples"
14. "CD30(+) anaplastic large-cell lymphoma in children: Analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology"
15. "Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies"
16. "High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children"
17. "Daunomycin plus COMP vs COMP therapy in childhood non-Hodgkin's lymphoma"
18. "Further evaluation of intensified and increased dose of cyclophosphamide for the treatment of primary breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project B-25"
19. "Mediastinal nonlymphoblastic lymphomas in children: A clinico-pathologic study"
20. "The prognostic significance of the immunotype in diffuse large-cell lymphoma: A comparative study of the T-cell and B-cell phenotype"
21. "Use of an anti-ALK antibody in the characterization of anaplastic large cell lymphoma of childhood"
22. "Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90"
23. "Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and 1 stage-a report of the Berlin-Frankfurt-Munster Group"
24. "A revised European-American classification oflymphoid neoplasms: A proposal from the International Lymphoma Study"